Structural Biology in Drug Discovery

Structural Biology in Drug Discovery

Methods, Techniques, and Practices

Renaud, Jean-Paul

John Wiley & Sons Inc

03/2020

688

Dura

Inglês

9781118681015

15 a 20 dias

1750

Descrição não disponível.
List of Contributors

Preface

Chapter 01: The Evolving Role of Structural Biology in Drug Discovery

Chapter 02: A Structural View on Druggability: Experimental and Computational Approaches

Chapter 03: Structural Chemogenomics: Profiling Protein-Ligand Interactions in Polypharmacological Space

Chapter 04: Fragment-Based Ligand Discovery

Chapter 05: Combining Structural, Thermodynamic and Kinetic Information to Drive Hit-to-Lead Progression

Chapter 06: Allostery as Structure-Encoded Collective Dynamics: Significance in Drug Design

Chapter 07: Biophysical Assessment of Target Protein Quality in Structure-Based Drug discovery

Chapter 08: An Industrial Perspective on Protein-Ligand Complex Crystallization

Chapter 09: Membrane Protein Crystallization

Chapter 10: High-throughput Macromolecular Crystallography in Drug Discovery: Evolving in the Midst of Revolutions

Chapter 11: Assessment of Crystallographic Structure Quality and Protein - Ligand Complex Structure Validation

Chapter 12: Complementary Information from Neutron Crystallography Studies

Chapter 13: Determination of Protein Structure and Dynamics by NMR: State of the Art and Application to the Characterization of Biotherapeutics

Chapter 14: NMR Studies of Protein - Small Molecule Interactions for Drug Discovery

Chapter 15: Computational Structural Biology for Drug Discovery: Power and Limitations

Chapter 16: The Role of Structural Biology in Kinase Inhibitors Drug Discovery Success

Chapter 17: Serine Proteinases from the Blood Coagulation Cascade

Chapter 18: Epigenetic Proteins as Emerging Drug Targets

Chapter 19: Impact of Recently Determined Crystallographic Structures of GPCRs on Drug Discovery

Chapter 20: Targeting Protein-Protein Interactions Perspective

Chapter 21: Mass Spectrometry-Based Strategies for Therapeutic Antibodies Extensive Characterization and Optimization (OptimAbs)

Chapter 22: Integrating Evolution of Drug Resistance into Drug Discovery: Lessons from the Viral Proteases of HIV-1 and HCV

Chapter 23: A Comprehensive Review on Mycobacterium Tuberculosis Targets and Drug Development from a Structural Perspective

Chapter 24: Using Crystal Structures of Drug-Metabolizing Enzymes in Mechanism-Based Modeling for Drug Design

Chapter 25: Intrinsically Disordered Proteins (IDPs): Targets for the Future?

Chapter 26: Cryo-electron Microscopy as a Tool for Drug Discovery in the Context of Integrative Structural Biology

Chapter 27: Application of Hard-X-ray Free-electron Lasers for Static and Dynamic Processes in Structural Biology
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
structural biology, drug discovery, drug development, crystallization, X-ray diffraction, NMR, mass spectrometry, and computational chemistry, protein dynamics, structure-based chemogenomics, polypharmacology, fragment-based drug design, biophysics, biotherapeutics